Similar articles for PMID: 21296371

Year	Number of Results
1987	1
1997	1
2004	1
2005	3
2006	2
2007	8
2008	11
2009	13
2010	13
2011	15
2012	13
2013	6
2014	12
2015	17
2016	12
2017	13
2018	15
2019	6
2020	12
2021	9
2022	9
2023	1
2024	0

1

[Paroxysmal nocturnal hemoglobinuria therapy with eculizumab: Spanish experience].

López Rubio M, Morado M, Gaya A, Alonso Rosa D, Ojeda E, Muñoz JA, Pérez de Mendiguren B, Monteagudo MD, Durán JM, Fisac RM, Moreno D, Villegas AM. López Rubio M, et al. Med Clin (Barc). 2011 Jun 11;137(1):8-13. doi: 10.1016/j.medcli.2010.09.035. Epub 2011 Feb 5. Med Clin (Barc). 2011. PMID: 21296371 Spanish.

2

Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

Hillmen P, Hall C, Marsh JC, Elebute M, Bombara MP, Petro BE, Cullen MJ, Richards SJ, Rollins SA, Mojcik CF, Rother RP. Hillmen P, et al. N Engl J Med. 2004 Feb 5;350(6):552-9. doi: 10.1056/NEJMoa031688. N Engl J Med. 2004. PMID: 14762182 Free article. Clinical Trial.

3

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, Röth A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L. Hillmen P, et al. N Engl J Med. 2006 Sep 21;355(12):1233-43. doi: 10.1056/NEJMoa061648. N Engl J Med. 2006. PMID: 16990386 Free article. Clinical Trial.

4

Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria.

Zareba KM. Zareba KM. Drugs Today (Barc). 2007 Aug;43(8):539-46. doi: 10.1358/dot.2007.43.8.1130446. Drugs Today (Barc). 2007. PMID: 17925885 Review.

5

Eculizumab for paroxysmal nocturnal haemoglobinuria.

Parker C. Parker C. Lancet. 2009 Feb 28;373(9665):759-67. doi: 10.1016/S0140-6736(09)60001-5. Epub 2009 Jan 12. Lancet. 2009. PMID: 19144399

6

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria.

Hillmen P, Elebute M, Kelly R, Urbano-Ispizua A, Hill A, Rother RP, Khursigara G, Fu CL, Omine M, Browne P, Rosse W. Hillmen P, et al. Am J Hematol. 2010 Aug;85(8):553-9. doi: 10.1002/ajh.21757. Am J Hematol. 2010. PMID: 20658586 Free article. Clinical Trial.

7

Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3.

Risitano AM, Perna F, Selleri C. Risitano AM, et al. Mini Rev Med Chem. 2011 Jun;11(6):528-35. doi: 10.2174/138955711795843301. Mini Rev Med Chem. 2011. PMID: 21561403 Review.

8

Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria.

Hill A, Rother RP, Hillmen P. Hill A, et al. Haematologica. 2005 Dec;90(12 Suppl):ECR40. Haematologica. 2005. PMID: 16464755

9

FDA report: eculizumab (Soliris) for the treatment of patients with paroxysmal nocturnal hemoglobinuria.

Dmytrijuk A, Robie-Suh K, Cohen MH, Rieves D, Weiss K, Pazdur R. Dmytrijuk A, et al. Oncologist. 2008 Sep;13(9):993-1000. doi: 10.1634/theoncologist.2008-0086. Epub 2008 Sep 10. Oncologist. 2008. PMID: 18784156 Free article. Clinical Trial.

10

Neutrophil activation and nucleosomes as markers of systemic inflammation in paroxysmal nocturnal hemoglobinuria: effects of eculizumab.

van Bijnen ST, Wouters D, van Mierlo GJ, Muus P, Zeerleder S. van Bijnen ST, et al. J Thromb Haemost. 2015 Nov;13(11):2004-11. doi: 10.1111/jth.13125. Epub 2015 Oct 19. J Thromb Haemost. 2015. PMID: 26333021 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

174 results

Results by year